E8-25034. Preparation for International Conference on Harmonization Meetings in Brussels, Belgium; Public Meeting; Amendment of Notice  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is announcing an amendment to the public meeting notice entitled “Preparation for ICH meetings in Brussels, Belgium.” This meeting was announced in the Federal Register of September 16, 2008 (73 FR 53428). The amendment is being made to reflect changes in the Location portion of the document. There are no other changes.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Tammie Jo Bell, Office of the Commissioner, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, by email: Tammie.Bell2@fda.hhs.gov or fax: 301-827-0003.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In the Federal Register of September 16, 2008, FDA announced that a preparation meeting for the International Conference on Harmonization will be held on October 21, 2008 from 2:30 p.m. to 5:30 p.m.

    On page 53428, in the first column, the Location portion of the document is amended to read as follows:

    Location: The meeting will be held at the Hilton Washington DC/ Rockville Hotel & Executive Meeting Center, Regency Room, 1750 Rockville Pike, Rockville, MD 20852. For directions please visit www.washingtondcrockville.hilton.com.

    The agenda for the public meeting will be made available via the internet at http://www.fda.gov/​cder/​meeting/​ICH_​20081021.htm.

    Start Signature

    Dated: October 15, 2008.

    Jeffrey Shuren,

    Associate Commissioner for Policy and Planning.

    End Signature End Supplemental Information

    [FR Doc. E8-25034 Filed 10-20-08; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Comments Received:
0 Comments
Published:
10/21/2008
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
E8-25034
Pages:
62514-62514 (1 pages)
Docket Numbers:
Docket No. FDA-2008-N-0484
PDF File:
e8-25034.pdf